AN3199 - CAS 1187187-10-5
Catalog number: 1187187-10-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C17H18BNO5
Molecular Weight:
327.14
COA:
Inquire
Targets:
PDE4
Description:
AN3199, a PDE4 inhibitor, was once studied as an anti-inflammatory agent. IC50: 94.5 nM
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
AN 3199; AN-3199
Solubility:
10 mM in DMSO
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
AN3199 is a PDE4 inhibitor and was once studied as an anti-inflammatory agent.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
InChIKey:
BJXLLSAUQIAPDB-UHFFFAOYSA-N
InChI:
InChI=1S/C17H18BNO5/c1-2-3-8-22-17(20)12-4-7-16(19-10-12)24-14-5-6-15-13(9-14)11-23-18(15)21/h4-7,9-10,21H,2-3,8,11H2,1H3
Canonical SMILES:
B1(C2=C(CO1)C=C(C=C2)OC3=NC=C(C=C3)C(=O)OCCCC)O
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PDE4 Products


CAS 608141-41-9 Apremilast

Apremilast
(CAS: 608141-41-9)

Apremilast (CC-10004)is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneo...

MK0873
(CAS: 500355-52-2)

MK0873 is a phosphodiesterase 4 (PDE4) inhibitor. It has shown as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans...

CAS 61413-54-5 Rolipram

Rolipram
(CAS: 61413-54-5)

Rolipram is a selective PDE4-inhibitor and an anti-inflammatory agent.

CP-220629
(CAS: 162141-96-0)

CP-220629, a Pyrazolopyridin derivative, has been found to be a Type 4 cyclic nucleotide phosphodiesterase inhibitor that was once studied as an anti-inflammato...

NVP-ABE-171
(CAS: 426268-06-6)

NVP-ABE171 is a potent and novel phosphodiesterase 4 inhibitor with anti-inflammatory activities inhibited the activity of phosphodiesterase 4A, 4B, 4C, and 4D ...

CAS 418794-42-0 Ronomilast

Ronomilast
(CAS: 418794-42-0)

Ronomilast is type 4 cyclic nucleotide phosphodiesterase inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).

CAS 1415560-64-3 GSK256066 2,2,2-trifluoroacetic acid

GSK256066 2,2,2-trifluoroacetic acid
(CAS: 1415560-64-3)

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold...

CAS 906673-24-3 crisaborole

crisaborole
(CAS: 906673-24-3)

Crisaborole is a novel PDE-4 inhibitor used as a nonsteroidal topical medication for the treatment of mild-to-moderate atopic dermatitis (eczema). Crisaborole s...

L-869298
(CAS: 362718-73-8)

L-869298 is a high potent and selective PDE4 inhibitor, acts as a Type 4 cyclic nucleotide phosphodiesterase inhibitor.

CAS 85416-73-5 S- (+)-Rolipram

S- (+)-Rolipram
(CAS: 85416-73-5)

S-(+)-Rolipram inhibits human monocyte cyclic AMP-specific PDE4 with IC50 of 0.75 μM, has anti-inflammatory and anti-depressant activity in the central nervous ...

CAS 101975-10-4 Zardaverine

Zardaverine
(CAS: 101975-10-4)

Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 μM and 0.8 μM respectively.

CP-671305
(CAS: 445295-04-5)

CP-671305 is a potent and selective inhibitor of PDE4.

AN3199
(CAS: 1187187-10-5)

AN3199, a PDE4 inhibitor, was once studied as an anti-inflammatory agent. IC50: 94.5 nM

CAS 162401-32-3 Roflumilast

Roflumilast
(CAS: 162401-32-3)

Roflumilast has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such ...

CAS 778576-62-8 Oglemilast

Oglemilast
(CAS: 778576-62-8)

Oglemilast is a potent PDE4 inhibitor and under clinical studies in the treatment of allergen-induced asthma.

CAS 801312-28-7 GSK256066

GSK256066
(CAS: 801312-28-7)

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selec...

CI-1044
(CAS: 197894-84-1)

CI-1044, a selective PDE4 inhibitor, inhibits in vitro LPS-induced TNF-alpha release in whole blood from COPD patients better than rolipram and cilomilast and s...

GSK-356278
(CAS: 720704-34-7)

GSK-356278 is a selective Type 4 cyclic nucleotide phosphodiesterase inhibitor. It shows anxiolytic and cognition-enhancing effects and it has the ability to el...

CAS 346629-30-9 MK-0359

MK-0359
(CAS: 346629-30-9)

MK-0359 is a selective and potent oral PDE4 inhibitor with in vivoefficacy in animal models of asthma and cognition.

CAS 329306-27-6 BAY 19-8004

BAY 19-8004
(CAS: 329306-27-6)

BAY 19-8004 is a selective inhibitor of phosphodiesterase-4 (PDE4) used for the treatment of COPD.

Quick Inquiry

Verification code

Featured Items